CALZARI, PAOLO
CALZARI, PAOLO
Universita' degli Studi di MILANO
Three-year observational study on the long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
2025 A. Chiei Gallo, G. Tavoletti, G. Avallone, E. Bono, F. Barei, P. Calzari, A.V. Marzano, S.M. Ferrucci
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres
2025 G. Tavoletti, A. Chiei-Gallo, L. Gargiulo, G. Avallone, L. Ibba, F. Barei, P. Calzari, A. Narcisi, A.V. Marzano, S.M. Ferrucci
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience
2025 F. Barei, P. Calzari, E. Pezzolo, M. Napolitano, M. Rossi, M.B. Guanti, F. Caroppo, A. Belloni Fortina, C. Patruno, A. Campanati, T. Bianchelli, G.M. D'Agostino, E. Nettis, F. Pugliese, V. Picone, I. Trave, E. Cozzani, L. Stingeni, K. Hansel, M. Dall'Olio, B. Galli, R. Coppola, V. Panasiti, M. Maurelli, G. Girolomoni, M. Ortoncelli, S. Ribero, A.V. Marzano, S. Ferrucci
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes
2025 F. Barei, P. Calzari, E. Pezzolo, M. Napolitano, M. Rossi, M.B. Guanti, F. Caroppo, A. Belloni Fortina, C. Patruno, A. Campanati, T. Bianchelli, G.M. D'Agostino, E. Nettis, F. Pugliese, F. Di Vico, I. Trave, E. Cozzani, L. Stingeni, K. Hansel, M. Dall'Olio, L. Grigolato, R. Coppola, V. Panasiti, M. Maurelli, G. Girolomoni, M. Ortoncelli, S. Ribero, A.V. Marzano, S.M. Ferrucci
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis
2025 G. Avallone, A. Bombelli, L. Valtellini, G. Tavoletti, B. Galli, M. Rossi, M. Maurelli, G. Girolomoni, L. Gargiulo, A. Narcisi, F. Di Vico, M. Napolitano, L. Lazzeri, L. Calabrese, S. Caccavale, A. Balato, F. Barei, P. Calzari, C. Foti, I. Trave, E. Cozzani, F. Rongioletti, S. Lenti, C. Gurioli, E. Nettis, F. Caroppo, E. Errichetti, L. Bonzano, N. Gori, K. Peris, S. Lembo, L. Del Regno, M. Esposito, M.C. Fargnoli, P. Savoia, E. Esposto, R. Giuffrida, F. Guarneri, C. Patruno, E. Pezzolo, L. Stingeni, K. Hansel, L. Mastorino, M. Ortoncelli, S. Ribero, A.V. Marzano, S.M. Ferrucci
Contact system activation and bradykinin generation in patients with idiopathic angioedema
2024 C. Suffritti, P. Calzari, F. Depetri, S. Griffini, E. Grovetti, R. Santacroce, M. Margaglione, M. Cugno
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
2024 R. Asero, P. Calzari, S. Vaienti, M. Cugno
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
2024 F. Barei, P. Calzari, L. Valtellini, A. Chiei Gallo, G. Perego, S. Tavecchio, M. Zussino, A.V. Marzano, S. Ferrucci
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
2024 P. Calzari, A. Chiei Gallo, F. Barei, E. Bono, M. Cugno, A.V. Marzano, S.M. Ferrucci
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
2023 S. Vaienti, P. Calzari, G. Nazzaro
Uses of Polypodium leucotomos Extract in Oncodermatology
2023 P. Calzari, S. Vaienti, G. Nazzaro
Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
2023 R. Asero, S.M. Ferrucci, P. Calzari, D. Consonni, M. Cugno
The role of imaging technologies in the diagnosis of hidradenitis suppurativa
2023 G. Nazzaro, P. Calzari, S. Vaienti, E. Passoni, A.V. Marzano
Lymph node involvement in axillary hidradenitis suppurativa: A clinical, ultrasonographic and bacteriological study conducted during radical surgery
2021 S. Vaienti, G. Nazzaro, A. Grancini, P. Calzari, G. Zaccaria, S. Veraldi, L. Vaienti
Vascularization and fibrosis are important ultrasonographic tools for assessing response to adalimumab in hidradenitis suppurativa: Prospective study of 32 patients
2021 G. Nazzaro, P. Calzari, E. Passoni, S. Vaienti, C. Moltrasio, M. Barbareschi, S. Muratori, S. Veraldi, A.V. Marzano